Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2007
08/16/2007US20070191463 Substituted melatonin derivatives, process for their preparation, and methods of use
08/16/2007US20070191462 Combination of A 5-HT(1) Receptor Agonist and an Alpha-2-Delta Ligand for the Treatment of Migraine
08/16/2007US20070191461 Use of benzo-heteroaryl sulfamide derivatives for the treatment of migraine
08/16/2007US20070191460 Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Disease Modification / Epileptogenesis
08/16/2007US20070191459 Use of Benzo-Heteroaryl Sulfamide Derivatives for Lowering Lipids and Lowering Blood Glucose Levels
08/16/2007US20070191458 Preparing an anhydrous crystal of a malic acid salt of N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide by reacting the acid and amine in a solvent and crystallizing under various process conditions
08/16/2007US20070191457 Compounds having activity at 5ht2c receptor and uses thereof
08/16/2007US20070191456 Novel process for the preparation of 1-(9h-carbazol-4-yloxy)-3-[[2-(-methoxyphenoxy)-ethyl] amino]-propan-2-ol
08/16/2007US20070191455 Substituted sym-triindole
08/16/2007US20070191453 Use of benzo-heteroaryl sulfamide derivatives for the treatment of substance abuse and addiction
08/16/2007US20070191452 Use of benzo-heteroaryl sulfamide derivatives for the treatment of pain
08/16/2007US20070191451 Use of benzo-heteroaryl sulfamide derivatives as neuroprotective agents
08/16/2007US20070191450 Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Mania and Bipolar Disorder
08/16/2007US20070191449 Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Depression
08/16/2007US20070191448 Ion channel modulators
08/16/2007US20070191447 Novel heterocyclic compound
08/16/2007US20070191446 Tubular proteinuria as an indicator for elevated cardiovascular risk
08/16/2007US20070191445 heat shock protein 90 inhibitors; antiproliferative agents; angiogenesis inhibitors
08/16/2007US20070191444 Benzimidazolyl derivatives
08/16/2007US20070191443 Methods and materials for assessing prostate cancer therapies and compounds
08/16/2007US20070191442 Aqueous Pharmaceutical Formulations of ER-beta Selective Ligands
08/16/2007US20070191441 Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatase 1b (ptb1b) inhibitors for using as blood-sugar decreasing active ingredients for treating diabetes
08/16/2007US20070191440 Methods of treating autism and fragile X syndrome
08/16/2007US20070191439 reacting propionic anhydride with N-(6-Amino-4,5,6,7-tetrahydro-benzothiazol-2-yl)-acetamide and subsequent reduction by treatment with NaBH4 and I2 to obtain amino derivative, deprotection of primary amino group to form pramipexole or salt formation of pramipexole
08/16/2007US20070191438 Methods for the treatment of hypertension
08/16/2007US20070191437 Continuous Dosing Regimen
08/16/2007US20070191436 Reduction of a keto ester of rosuvastatin in an organic solvent, hydrolysis; chemical intermediates
08/16/2007US20070191435 Hydrochloride salt of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione
08/16/2007US20070191434 Inhibitors of bacterial IMPDH
08/16/2007US20070191433 Dietetics; antidiabetic agents; sexual disorders
08/16/2007US20070191432 Novel benzo[D][1,3]-dioxol derivatives
08/16/2007US20070191431 2-Amino-5-piperidinylimidazolone compounds and use thereof for beta-secretase modulation
08/16/2007US20070191430 Method of providing anesthesia
08/16/2007US20070191429 Ppar activators
08/16/2007US20070191428 Anhydrous crystalline fexofenadine hydrochloride Form C, crystalline fexofenadine acetate monohydrate Form D, crystalline fexofenadine acetate dihydrate Form E, crystalline fexofenadine free base monohydrate Form F; H1 receptor antagonist; antihistaminic drug; reduction of ketonic form, salt formation
08/16/2007US20070191427 Use of n-piperidine derivatives for the treatment of neurodegenerative pathologies
08/16/2007US20070191426 Derivatives of 3-aminocarbonylquinoline, pharmaceutical compositions containing them and processes and intermediates for their preparation
08/16/2007US20070191425 Solifenacin-containing composition
08/16/2007US20070191424 such as (2R)-2-{(1S)-6,7-dimethoxy-1-[2-(4-trifluoromethyl-phenyl)-ethyl]-3,4-dihydro-1H-isoquinolin-2-yl}-N-methyl-2-phenyl-acetamide, used as orexin receptor antagonists, for preventing or treating sleep disorders
08/16/2007US20070191423 Isoquinoline derivatives
08/16/2007US20070191422 Nicotinic acetylcholine receptor ligands
08/16/2007US20070191421 Aryl-isoxazol-4-yl-imidazo[1,5-a]pyridine derivatives
08/16/2007US20070191420 Kinase inhibitors
08/16/2007US20070191419 (6R,8S)-6-(spiro[isobenzofuran-1-(3H), 4'-piperidin]-1'-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-ol), exhibiting an antagonism to binding of nociceptin to opioid receptor-like-1 receptors, useful as medicines for diseases associated with pain and appetite control or memory and learning
08/16/2007US20070191418 Modulating acid-sensitive ion channels to treat pain, neurological diseases, gastrointestinal diseases, urogenital diseases, and inflammation
08/16/2007US20070191417 Quinoline 3-amino chroman derivatives
08/16/2007US20070191416 [2-(3,4,5-trimethoxy-benzoyl)-1,2,3,4-tetrahydro-pyrido[4,3-b]indol-5-yl]-acetic acid; allergic asthma, rhinitis, allergic nephritis, conjunctivitis, atopic dermatitis, bronchial asthma, food allergy, anaphylactic shock, urticaria, eczema, itching, Churg-Strauss syndrome, or sinusitis
08/16/2007US20070191415 Production of tacrolimus (fk-506) using new streptomyces species
08/16/2007US20070191414 Novel isoamido-substituted hydroxy-6-phenylphenanthridines
08/16/2007US20070191413 Novel heterocycle-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
08/16/2007US20070191412 Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor
08/16/2007US20070191411 Enhancement of impaired motor and mental functions, using dextromethorphan and oxidase enzyme inhibitor
08/16/2007US20070191410 Cyclopamine analogues and methods of use thereof
08/16/2007US20070191409 Compounds for inhibiting beta-amyloid production and methods of identifying the compounds
08/16/2007US20070191408 Nutraceutical; vitamin B, amine oxidase enzyme inhibitor of semicarbazide-sensitive amine oxidases; additive to a foodstuff or as a dietary supplement; atherosclerosis, vascular retinopathies, retinopathy, glomerulosclerosis, nephropathy, nephrotic syndrome, polyneuropathy, mononeuropathies
08/16/2007US20070191407 catalytic chemical preparation of intermediate 4-(2-cyanoethenyl)-2,6-dimethylbenzenamine stereoisomers in presence of palladium chloride; having HIV inhibiting properties
08/16/2007US20070191406 Heterocyclic antiviral compounds
08/16/2007US20070191405 Bi-aryl meta-pyrimidine inhibitors of kinases
08/16/2007US20070191404 Pharmaceutical compositions of pyrimidine-2,4,6-triones
08/16/2007US20070191403 e.g. 3-[{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4(1H,3H)-dione; sex-hormone related diseases; anticarcinogenic agent; endometriosis, uterine fibroids, polycystic ovarian disease
08/16/2007US20070191402 Method of searching substrate having antidiabetic activity
08/16/2007US20070191401 Transplant rejection, autoimmune disease, autoimmune disease
08/16/2007US20070191400 Pharmaceutical compositions comprising anti-inflammatory quinazolinecarboxamide derivatives
08/16/2007US20070191399 Zaleplon synthesis
08/16/2007US20070191395 Heterocyclic compounds having antifungal activity
08/16/2007US20070191394 3-[2-(3-Ethyl-ureido)-7-pyridin-3-yl-imidazo[1,2-a]pyridin-5-yl]-[1,2,4]oxadiazole-5-carboxylic acid methylamide; antibiotic resistance; grampositive, gramnegative, anaerobic bacteria; otitis; sinusitis, pharyngitis/tonsilitis, bronchitis, urinary tract infections, skin infections, pneumonia, septicemia
08/16/2007US20070191393 Macrocyclic anilinopyrimidines with substituted sulphoximine as selective inhibitors of cell cycle kinases
08/16/2007US20070191392 Dipeptide nitrile cathespin k inhibitors
08/16/2007US20070191391 Urotensin II receptor antagonists
08/16/2007US20070191390 Substituted heterocyclic compounds
08/16/2007US20070191389 substituted with five-membered heterocyclics such as isopropyl 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-[1,2,3]triazol-4-yl]-1,2,3,6-tetrahydropyridine-1-carboxylate, having glutamate receptor antagonistic activity used in the treatment of convulsions, pain, infarction, ischemia or psychological disorders
08/16/2007US20070191388 1-Benzyl-4-[4-(thiophene-2-carbonyl) piperazin-1-yl]-2-oxo-1,2-dihydro-3-cyano[1,8]-naphthyridine; antinflammatory, antiarthritic, anticarcinogenic, antitumor, antidiabetic; septic shock; acute respiratory distress syndrome; casrdiovascular disorders; angiogenesis inhibitors; autoimmune diseases; asthma
08/16/2007US20070191387 Substituted dihydroquinazolines
08/16/2007US20070191386 Bicyclo-pyrazole compounds specially pyrrolo[3,4-c]pyrazole or tetrahydropyridine[4,3-c]pyrazole derivatives; anticarcinogenic agents; N-{5-phenylacetyl-4,6-dihydropyrrolo[3,4-c]pyrazol-3-yl}phenylacetamide; modulators of apoptosis; combinatorial chemical library with an isocyanate polystyrenic resin
08/16/2007US20070191385 4-(O-(2-(biphenylmethyl)-4-phenylimidazol-1-yl)phenyl)-1,2,5-thiadiazolidine-3-one derivatives; used to treat type I and type II diabetes
08/16/2007US20070191384 9-(2-Oxo-2-phenyl-ethyl)-2-(4-pyridinyl)-8-(trifluoromethyl)-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; glycogen synthase kinase 3 beta and tau protein kinase inhibitor; neurodegenerative diseases: Alzheimer's disease, vascular dementia; acute stroke, retinopathy, glaucoma, alopecia
08/16/2007US20070191383 Mtp inhibiting aryl piperydines or piperazines substituted with 5-membered heterocycles
08/16/2007US20070191382 potassium channel modulators; 3-(4,6-Dioxo-2,3,4,6,7,8,9,10-octahydro-1H-phenazin-5-yl)-benzonitrile; urinary incontinence, overactive bladder, hypertension, erectile dysfunction, sexual disorders, dysmenorrhea, irritable bowel syndrome, epilepsy, stroke, Alzheimer's and Parkinson's diseases
08/16/2007US20070191381 Novel pharmaceutical compounds
08/16/2007US20070191380 Kinase inhibitor scaffolds and methods for their preparation
08/16/2007US20070191379 ABCA1 elevating compounds
08/16/2007US20070191378 Anthranilic acid derivatives and their use as activators of the hm74a receptor
08/16/2007US20070191377 Methods for treating blood disorders with nitric oxide donor compounds
08/16/2007US20070191376 Bicyclic heteroaryl compounds
08/16/2007US20070191375 CRYSTALLINE FORMS OF (3R,4R)-4-AMINO-1-[[4-[(3-METHOXYPHENYL)AMINO]PYRROLO[2,1-f][1,2,4]TRIAZIN-5-YL]METHYL]PIPERIDIN-3-OL
08/16/2007US20070191374 Substituted cinnolin-4-ylamines
08/16/2007US20070191373 Heterocyclic compounds for use in the treatment of viral infections
08/16/2007US20070191372 Dna-targeted benzotriazine 1,4-dioxides and their use in cancer therapy
08/16/2007US20070191371 Heterocyclic modulators of ppar
08/16/2007US20070191370 Multicyclic amino acid derivatives and methods of their use
08/16/2007US20070191369 Inhibitors of c-Met and uses thereof
08/16/2007US20070191368 Inhibition of tissue damage to skin from radiation treatment therapy
08/16/2007US20070191367 3-spiroindolin-2-one derivatives, preparation and therapeutic use thereof
08/16/2007US20070191366 Use of effectors of glutaminyl and glutamate cyclases
08/16/2007US20070191365 3,4,6-Substituted pyridazines for treating neuropathic pain and associated syndromes
08/16/2007US20070191364 Aminopiperidine derivatives, preparation thereof and therapeutic use thereof
08/16/2007US20070191363 Heteroalkyl-substituted biphenyl-4-carboxylic acid arylamide analogues
08/16/2007US20070191362 such as (2E)-2-[1-(2,4-difluoro-phenyl)-6-(3-fluoro-benzyl)-1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl]-ethenesulfonic acid [(1S)-1-phenyl-ethyl]-amide, used for treating diabetes, vision defects, pain, drug abuse, gastrointestinal and respiratory system isorders, as muscle relaxants and neuroprotectants
08/16/2007US20070191361 Aminotropane derivatives, preparation thereof and therapeutic use thereof
08/16/2007US20070191360 antitumor agents; viricides
1 ... 3623 3624 3625 3626 3627 3628 3629 3630 3631 3632 3633 3634 3635 3636 3637 3638 3639 3640 3641 3642 3643 ... 7860